These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7497854)

  • 41. The STOP-NIDDM Trial: an international study on the efficacy of an alpha-glucosidase inhibitor to prevent type 2 diabetes in a population with impaired glucose tolerance: rationale, design, and preliminary screening data. Study to Prevent Non-Insulin-Dependent Diabetes Mellitus.
    Chiasson JL; Gomis R; Hanefeld M; Josse RG; Karasik A; Laakso M
    Diabetes Care; 1998 Oct; 21(10):1720-5. PubMed ID: 9773737
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A model for early diagnosis of type 2 diabetes mellitus in primary health care.
    Andersson DK; Lundblad E; Svärdsudd K
    Diabet Med; 1993 Mar; 10(2):167-73. PubMed ID: 8458195
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of diabetes mellitus (NIDDM).
    Ito C; Maeda R; Nakamura K; Sasaki H
    Diabetes Res Clin Pract; 1996 Oct; 34 Suppl():S7-11. PubMed ID: 9015664
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [What will be the proper criteria for impaired fasting glucose for Korean men? Based on medical screening data from a general hospital].
    Ryu S; Chang YS; Kim DI; Suh BS; Kim WS
    J Prev Med Public Health; 2005 May; 38(2):203-7. PubMed ID: 16315759
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus.
    Chen YD; Swami S; Skowronski R; Coulston A; Reaven GM
    J Clin Endocrinol Metab; 1993 Jan; 76(1):172-7. PubMed ID: 8421086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Multicenter study on screen method for gestational diabetes].
    Wu LF; Liu DY; Huang XH; Zu XS; Yang M; Liu WJ; Heng ZH; Chi XZ; Jia XF; Hu MH
    Zhonghua Fu Chan Ke Za Zhi; 2003 Mar; 38(3):132-5. PubMed ID: 12816684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Capillary glucose determination in the screening of gestational diabetes.
    Meriggi E; Trossarelli GF; Carta Q; Menato G; Porta MA; Bordon R; Gagliardi L
    Diabetes Res Clin Pract; 1988 May; 5(1):55-61. PubMed ID: 3402333
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Resting heart rate as a marker for identifying the risk of undiagnosed type 2 diabetes mellitus: a cross-sectional survey.
    Li YQ; Sun CQ; Li LL; Wang L; Guo YR; You AG; Xi YL; Wang CJ
    BMC Public Health; 2014 Oct; 14():1052. PubMed ID: 25297916
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Performance of existing risk scores in screening for undiagnosed diabetes: an external validation study.
    Witte DR; Shipley MJ; Marmot MG; Brunner EJ
    Diabet Med; 2010 Jan; 27(1):46-53. PubMed ID: 20121888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Glycosuric tests should not be employed in population screenings for NIDDM.
    Friderichsen B; Maunsbach M
    J Public Health Med; 1997 Mar; 19(1):55-60. PubMed ID: 9138218
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Analysis of the diabetes mellitus screening program in the Federal District, Mexico].
    Alvear-Galindo MG; Laurell AC
    Cad Saude Publica; 2010 Feb; 26(2):299-310. PubMed ID: 20396845
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Capillary blood sample for type 2 diabetes screening: fingertip versus forearm].
    Cuevas Fernández FJ; Iglesias Girón MJ; Gómez de Segura IL; Aguirre-Jaime A
    Med Clin (Barc); 2004 Jul; 123(5):174-6. PubMed ID: 15274795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evolution of analytical performance in portable glucose meters in the last decade.
    Böhme P; Floriot M; Sirveaux MA; Durain D; Ziegler O; Drouin P; Guerci B
    Diabetes Care; 2003 Apr; 26(4):1170-5. PubMed ID: 12663592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ADA Diabetes Risk Test Adaptation in Indonesian Adult Populations: Can It Replace Random Blood Glucose Screening Test?
    Harbuwono DS; Mokoagow MI; Magfira N; Helda H
    J Prim Care Community Health; 2021; 12():21501327211021015. PubMed ID: 34053367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of a type 2 diabetes screening tool in rural Honduras.
    Milton EC; Herman WH; Aiello AE; Danielson KR; Mendoza-Avelarez MO; Piette JD
    Diabetes Care; 2010 Feb; 33(2):275-7. PubMed ID: 19918008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inpatient Glucose Values: Determining the Nondiabetic Range and Use in Identifying Patients at High Risk for Diabetes.
    Rhee MK; Safo SE; Jackson SL; Xue W; Olson DE; Long Q; Barb D; Haw JS; Tomolo AM; Phillips LS
    Am J Med; 2018 Apr; 131(4):443.e11-443.e24. PubMed ID: 28993187
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Community screening for diabetes. Low detection rate in a low-risk population.
    Newman WP; Nelson R; Scheer K
    Diabetes Care; 1994 May; 17(5):363-5. PubMed ID: 8062600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Screening for NIDDM in nonpregnant adults. A review of principles, screening tests, and recommendations.
    Engelgau MM; Aubert RE; Thompson TJ; Herman WH
    Diabetes Care; 1995 Dec; 18(12):1606-18. PubMed ID: 8722060
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effectiveness of mass screening for diabetes mellitus using random capillary blood glucose measurements.
    Moses RG; Colagiuri S; Shannon AG
    Med J Aust; 1985 Dec 9-23; 143(12-13):544-6. PubMed ID: 3831744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.